Treatment of Systemic Sclerosis Associated Interstitial Lung Disease
2020 ◽
Vol 20
(02)
◽
pp. 56-64
Keyword(s):
Systemic sclerosis (SSc) is a systemic connective tissue disorder characterized by progressive skin and visceral organ fibrosis, vasculopathy, and immune dysregulation. Interstitial lung disease (ILD) is a common manifestation and major contributor to morbidity and mortality. Immunosuppression is usually indicated for extensive or progressive SSc-ILD. Recently, antifibrotic and biological therapies have been shown to be efficacious in treating SSc-ILD in various studies. In this article, we will descriptively review the latest evidence on the treatment of SSc-ILD.
2019 ◽
Vol 4
(3)
◽
pp. 212-218
◽
Keyword(s):
2019 ◽
Vol 15
(10)
◽
pp. 1009-1017
◽
2019 ◽
Vol 380
(26)
◽
pp. 2518-2528
◽